852391-54-9 Usage
Molecular Weight
211.29 g/mol The molecular weight of 1H-Indole, 7-butoxyis 211.29 g/mol, which is the mass of one mole of the compound.
Chemical Class
Indole 1H-Indole, 7-butoxybelongs to the indole class of organic compounds, which are derivatives of the indole ring system.
Substitution
Butoxy group at the 7th position 1H-Indole, 7-butoxyis a derivative of indole with a butoxy group (C4H9O) attached to the 7th position of the indole ring.
Usage
Synthesis of pharmaceuticals and organic compounds 1H-Indole, 7-butoxyis used as an intermediate in the synthesis of various pharmaceuticals and other organic compounds.
Industrial Applications
Production of dyes, perfumes, and other chemicals The compound is also utilized in the production of dyes, perfumes, and other industrial chemicals.
Biological Activities
Potential applications in the pharmaceutical and agrochemical industries 1H-Indole, 7-butoxyexhibits certain biological activities, making it potentially useful in the development of pharmaceuticals and agrochemicals.
Safety Precautions
Proper handling and storage required Due to its chemical properties and potential risks, it is important to follow proper handling and storage measures when working with 1H-Indole, 7-butoxy-.
Check Digit Verification of cas no
The CAS Registry Mumber 852391-54-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,2,3,9 and 1 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 852391-54:
(8*8)+(7*5)+(6*2)+(5*3)+(4*9)+(3*1)+(2*5)+(1*4)=179
179 % 10 = 9
So 852391-54-9 is a valid CAS Registry Number.
852391-54-9Relevant articles and documents
Inhibitors of cellular necrosis
-
Page/Page column 39, (2008/06/13)
The present invention relates to compounds and pharmaceutical preparations and their use in therapy for preventing or treating trauma, ischemia, stroke and degenerative diseases associated with cell death. Methods and compositions of the invention are particularly useful for treating neurological disorders associated with cellular necrosis.
